GE HealthCare has introduced the Venue Sprint, a new tablet-based ultrasound device, alongside enhancements to its existing Venue family of point-of-care ultrasound (POCUS) systems. The launch aims to address the growing demand for portable, high-quality imaging solutions in various clinical settings.
GE HealthCare has introduced the Versana Premier, a new multi-purpose ultrasound system designed to meet the diverse needs of healthcare professionals across various clinical specialties. The system, which forms part of the Versana ultrasound family, incorporates artificial intelligence (AI) and automated productivity tools to streamline workflow and improve clinical efficiency.
Catalyst OrthoScience, a medical technology company specialising in shoulder arthroplasty, has announced FDA 510(k) clearance for its Catalyst Fracture Shoulder System. The system, designed for reverse shoulder arthroplasty in cases of proximal humeral fractures (PHFs), aims to tackle the complexities associated with tuberosity fixation and healing.
bioAffinity Technologies’ Vice President of Diagnostics, Dr Jennifer Rebeles, has contributed to a new set of guidelines for flow cytometry testing on rare matrix samples. The peer-reviewed paper, published in Cytometry Part B: Clinical Cytometry, addresses the challenges and considerations in validating assays with unique sample types.
AtriCure has announced regulatory approval for the sale of its EnCompass® Clamp in CE-marked countries within the European Union. This development follows the device’s FDA 510(K) clearance and subsequent launch in the United States in 2022.
FUJIFILM Healthcare Europe has announced that its high-end ultrasound system, the ARIETTA 750 FF ENDO, is now compatible with FUJIFILM’s ultrasound endoscopes and endobronchial ultrasound scope. This advancement allows clinicians to fully leverage FUJIFILM’s endoscopic technology during diagnostic and therapeutic procedures.
Vitestro, a Dutch medical robotics firm, has announced that its autonomous blood drawing device has received CE marking, making it the first such device to be approved for commercial use in the European Union. This milestone, achieved in July 2024, signifies the device’s compliance with the European Medical Device Regulation (MDR) standards for safety and […]
Neurotechnology firm Synchron has announced the incorporation of OpenAI’s generative artificial intelligence (AI) into its brain-computer interface (BCI) platform, introducing a novel chat feature. This integration aims to enhance the capabilities of Synchron’s BCI technology, enabling individuals with severe paralysis and loss of upper limb mobility to interact with digital interfaces through thought alone.
Oticon Medical has announced that its Sentio System, the company’s first active transcutaneous bone conduction hearing system, has received clearance from the U.S. Food and Drug Administration (FDA). This innovative system aims to provide the established benefits of the company’s Ponto System whilst offering a transcutaneous option.
Royal Philips has announced the successful first implantation of its Duo Venous Stent System following premarket approval from the U.S. Food and Drug Administration. The device is indicated for treating symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
